Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Villarreal

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Contact Dermatitis|April 16, 1998
Reliability of diagnostic tests for contact allergy to mydriatic eyedropsO Villarreal
Current Opinion in Immunology|April 26, 2014
Interleukin 33: a switch-hitting cytokineDaniel O Villarreal, David B Weiner
Expert Review of Vaccines|February 7, 2015
IL-33 isoforms: their future as vaccine adjuvants?Daniel O Villarreal, David B Weiner
Human Vaccines & Immunotherapeutics|June 20, 2015
Alarmin IL-33 elicits potent TB-specific cell-mediated responsesDaniel O Villarreal, Rebekah J Siefert, David B Weiner
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
DNA Vaccines: A Strategy for Developing Novel Multivalent TB VaccinesJaemi S Chu, Daniel O Villarreal, David B Weiner
Human Vaccines & Immunotherapeutics|June 21, 2016
A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosisKristin L Griffiths, Daniel O Villarreal, David B Weiner, et al.
Advances in Experimental Medicine and Biology|March 12, 2015
Synthetic DNA approach to cytomegalovirus vaccine/immune therapyStephan J Wu, Daniel O Villarreal, Devon J Shedlock, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCGDaniel O Villarreal, Jewell Walters, Dominick J Laddy, et al.
Molecular Medicine (Cambridge, Mass.)|July 23, 1999
Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicityG I Botchkina, E Geimonen, M L Bilof, et al.
Medicina Cutanea Ibero-Latino-Americana|January 1, 1989
[Purpura fulminans. Presentation of a clinical case]M A Villarreal Arredondo, O Villarreal González, D Escobedo Flores, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Contact Dermatitis|April 16, 1998
Reliability of diagnostic tests for contact allergy to mydriatic eyedropsO Villarreal
Current Opinion in Immunology|April 26, 2014
Interleukin 33: a switch-hitting cytokineDaniel O Villarreal, David B Weiner
Expert Review of Vaccines|February 7, 2015
IL-33 isoforms: their future as vaccine adjuvants?Daniel O Villarreal, David B Weiner
Human Vaccines & Immunotherapeutics|June 20, 2015
Alarmin IL-33 elicits potent TB-specific cell-mediated responsesDaniel O Villarreal, Rebekah J Siefert, David B Weiner
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
DNA Vaccines: A Strategy for Developing Novel Multivalent TB VaccinesJaemi S Chu, Daniel O Villarreal, David B Weiner
Human Vaccines & Immunotherapeutics|June 21, 2016
A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosisKristin L Griffiths, Daniel O Villarreal, David B Weiner, et al.
Advances in Experimental Medicine and Biology|March 12, 2015
Synthetic DNA approach to cytomegalovirus vaccine/immune therapyStephan J Wu, Daniel O Villarreal, Devon J Shedlock, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCGDaniel O Villarreal, Jewell Walters, Dominick J Laddy, et al.
Molecular Medicine (Cambridge, Mass.)|July 23, 1999
Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicityG I Botchkina, E Geimonen, M L Bilof, et al.
Medicina Cutanea Ibero-Latino-Americana|January 1, 1989
[Purpura fulminans. Presentation of a clinical case]M A Villarreal Arredondo, O Villarreal González, D Escobedo Flores, et al.
Pageof 3